Abstract
Over 900 children were enrolled in a double-blind placebo-controlled clinical study of measles (Schwarz strain), mumps (Jeryl Lynn strain), and rubella (Cendehill strain) trivalent vaccine. The trivalent vaccine caused about the same degree of reactivity as is generally associated with the Schwarz strain measles vaccine. Paired sera from triplesusceptible vaccinees had seroconversion rates of 99% for measles, 94% for mumps, and 93% for rubella. The results of this study show that this trivalent vaccine is as well tolerated and as effective as its component vaccines.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andelman M. B., Schwarz A., Spiegelblatt H. Field trials with further attenuated live measles vaccine without gamma globulin. Am J Public Health Nations Health. 1966 Nov;56(11):1891–1897. doi: 10.2105/ajph.56.11.1891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kenny M. T., Albright K. L., Sanderson R. P. Microneutralization test for the determination of mumps antibody in vero cells. Appl Microbiol. 1970 Sep;20(3):371–373. doi: 10.1128/am.20.3.371-373.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Linnemann C. C., Jr, Rotte T. C., Schiff G. M., Youtsey J. L. A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol. 1972 Mar;95(3):238–246. doi: 10.1093/oxfordjournals.aje.a121391. [DOI] [PubMed] [Google Scholar]
- ROSEN L. Hemagglutination and hemagglutination-inhibition with measles virus. Virology. 1961 Jan;13:139–141. doi: 10.1016/0042-6822(61)90042-3. [DOI] [PubMed] [Google Scholar]